首页> 外文期刊>Surgical pathology clinics >Cutaneous CD30-positive lymphoproliferative disorders
【24h】

Cutaneous CD30-positive lymphoproliferative disorders

机译:皮肤CD30阳性淋巴组织增生性疾病

获取原文
获取原文并翻译 | 示例
       

摘要

Cutaneous CD30+ lymphoproliferative disorders are the second most common types of cutaneous T-cell lymphomas. They represent a well-defined spectrum encompassing lymphomatoid papulosis (LyP), primary cutaneous anaplastic large-cell lymphoma (pcALCL), and borderline lesions. They share the expression of CD30 as a common phenotypic hallmark, but they differ in their clinical presentation, course, and histologic features. New variants have been recently identified, including CD8+ epidermotropic LyP type D, angioinvasive LyP type E, and ALK-positive pcALCL. This review describes clinical, histopathologic, and phenotypic variants; their differential diagnoses (benign and malignant); and the role of CD30 as a diagnostic, prognostic, and therapeutic marker.
机译:皮肤CD30 +淋巴增生性疾病是第二大最常见的皮肤T细胞淋巴瘤。它们代表了明确的频谱,包括淋巴瘤样丘疹病(LyP),原发性皮肤间变性大细胞淋巴瘤(pcALCL)和边缘性病变。它们具有共同表达CD30的表型特征,但在临床表现,病程和组织学特征上却有所不同。最近发现了新的变体,包括CD8 +表皮性LyP型D,血管浸润型LyP E和ALK阳性pcALCL。这篇综述描述了临床,组织病理学和表型变异;他们的鉴别诊断(良性和恶性);以及CD30作为诊断,预后和治疗标志物的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号